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One important pharmacological function of hyaluronic acid (HA) in chondrocytes is reduction of
cellular superoxide generation and accumulation. Here we demonstrated a relationship between
HA supplementation and accumulation of Nuclear factor-erythroid-2-related factor 2 (Nrf2), which
is a master transcription factor in cellular redox reactions, in cultured chondrocytes derived from
bovine joint cartilage. In HA-treated chondrocytes, expression of Nrf2 and its downstream genes
was upregulated. In HA-treated chondrocytes, Akt was phosphorylated, and inhibition of Akt activ-
ity or suppression of HA receptors CD44 and/or RHAMM with siRNAs prevented HA-mediated Nrf2
accumulation. Furthermore, Nrf2 siRNA inhibited the HA effect on antioxidant enzymes. These
results show that HA might contribute to ROS reduction through Nrf2 regulation by activating
Akt. Our study suggests a new mechanism for extracellular matrix (ECM)-mediated redox systems
in chondrocytes.
 2015 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies. This
is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).1. Introduction
Articular cartilage is a unique tissue in which a single resident
cell type, the chondrocyte exists in a speciﬁc environment that is
avascular, aneural, alymphatic, but consist of abundant extracellu-
lar matrix (ECM) with a tissue speciﬁc pattern of proteoglycans
(PGs), glycoproteins, collagens and hyaluronic acid (HA) [1–4].
This macromolecular assembly directly relates to maintenance of
the chondrocyte phenotype [5–7]. HA is a major component of
the cartilage ECM and synovial ﬂuid [1,2,8]. It has been thought
that the main biomechanical functions of HA are in lubrication
and compressive stiffness of the tissue [9–11]. In osteoarthritis
(OA)-affected joints, HA is modiﬁed through enzymatic degrada-
tion and oxidation, leading to compromised function [12,13]. In
vitro studies have examined HA effects on cartilage tissue and cells
[14,15]. For example, HA supplementation can promote
normalization of the cartilage ECM environment, and have
anti-inﬂammatory activities [16,17]. One of the important func-
tions of HA is the control of oxidative damage [18]. We reported
that HA reduces reactive oxygen species (ROS) production in
mechanical stress-loaded bovine cartilage [19]. However,molecular mechanisms how HA participates in the control of ROS
have not been elucidated.
Oxidative stress is caused by an imbalance between the produc-
tion of ROS and biological detoxiﬁcation systems, which are
induced by inﬂammation, infection or excessive mechanical stres-
ses [19–22]. Increased generation of ROS leads to acceleration of
tissue injury, dysfunction and degradation by promoting cell death
and ECM remodeling [23,24]. Under physiological conditions, the
superoxide anions are detoxiﬁed by numerous antioxidants and
phase II detoxifying enzymes such as catalase, superoxide dismu-
tases (SODs), heme oxygenase-1 (HO-1), glutathione S-tra
nsferase, glutathione peroxidase, and thioredoxin. These enzymes
are coordinated at transcription level by Nuclear factor-
erythroid-2-related factor 2 (Nrf2) [25,26]. Nrf2 is constitutively
expressed in all tissues of vertebrates and invertebrates. It plays
an important role in maintaining cell survival and integrity by
enhancing the protective capacity against oxidative stress [27]. In
fact, disruption of Nrf2 in mice diminishes or abrogates the induc-
tion of these antioxidant genes, and contributes to susceptibility to
neurodegenerative [28–30], cardiovascular [31,32], pulmonary
[33,34], renal [35,36] and liver diseases [37,38].
By considering the above three facts that (1) ECM can alter
chondrocyte gene expression, (2) HA can function as an antioxi-
dant in cartilage and (3) protection against ROS is controlled by
Nrf2 at the transcription level, we propose the hypothesis that
the redox potential of HA may be related to enhancement of the
Table 1
Sequences of siRNA duplexes used in the present study.
Sense Antisense
Nrf2-1 GUAACUGCAGCCCACAUUUTT AAAUGUGGGCUGCAGUUACTT
Nrf2-2 GAGACUAGUACAGUUCCAATT UUGGAACUGUACUAGUCUCTT
Nrf2-3 CAAAGAAAGAAGUACCUGUTT ACAGGUACUUCUUUCUUUGTT
CD44-1 GGAGAAGAAUGGUCGCUAUTT AUAGCGACCAUUCUUCUCCTT
CD44-2 CCAGAGAAUACCUCGGAUATT UAUCCGAGGUAUUCUCUGGTT
CD44-3 CUACAGACUCCUUGGAAAATT UUUUCCAAGGAGUCUGUAGTT
RHAMM-1 GCAUGUUGUGAAAUUGAAAT UUUCAAUUUCACAACAUGCTT
RHAMM-2 GCCUUAAGCAGUCUCUUGATT UCAAGAGACUGCUUAAGGCTT
RHAMM-3 GGUGUUUGAUUAAUAUUUATT UAAAUAUUAAUCAAACACCTT
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we examine the regulation of Nrf2 expression in chondrocytes
and effect of HA to Nrf2 expression using bovine articular chondro-
cytes in vitro.
2. Materials and methods
2.1. Culture and treatment of bovine primary articular chondrocytes
Full thickness articular cartilage tissues were collected from the
condylar ridge of the metacarpophalangeal joints of freshly slaugh-
tered calves about 10 months of age, which were donated from a
local slaughterhouse. Chondrocytes were isolated from the articu-
lar cartilage by enzymatic digestion with 2 mg/ml of collagenase
(Wako Pure Chemical Industries, Osaka, Japan) for 12 h at 37 C.
After ﬁltration, cells were seeded in culture plates and cultured
in 10% FCS supplemented aMEM at 37 C and 5% CO2, 5% O2 for
48 h. In the experiments, the medium was changed to serum-free
medium consisting of 0.5% bovine serum albumin (BSA, Sigma–
Aldrich, St. Louis, MO, USA), DMEM/F12 (Life Technologies Inc.,
Carlsbad, CA, USA), 2 mM L-glutamine (Wako Pure Chemical
Industries, Tokyo, Japan), 1% insulin-transferrin selenium (Life
technologies) and 1% antibiotic/antimycotic solution (Life
Technologies). Cells were cultured under these conditions for
24 h when the following reagents were added; 1 mM H2O2
(Wako Pure Chemical Industries), 10% hyaluronic acid (ARTZ,
approx. 500,000–700,000 MW, Kaken Pharmaceutical Co., Ltd.,
Tokyo, Japan), 20 lM LY294002 (Sigma–Aldrich) and same amount
of DMSO as a control of LY294002 (Sigma–Aldrich).
2.2. Measurement of intracellular reactive oxygen species (ROS)
Generation of the ROS was detected using CellROX Green
Reagent for oxidative stress detection (Life technologies). Bovine
chondrocytes at passage 2 were seeded on 48-well plate and incu-
bated with H2O2 with/without HA for 2 h. After washing twice with
culture medium, the cells were treated with CellROX GreenTable 2
Primers for qPCR used in the present study.
Forward
Sox9 GTACCCGCACCTGCACAAC
Col2A1 TGGTATCGCCGGACCCAAG
ADAMTS-5 TCACCAGCATTGACGCATC
HO-1 ACTTTCAGAAGGGTGAGCTGA
NQO-1 TCATCTCCAGAAAGGACATC
GPX-1 TGCAACCAGTTTGGGCATC
Catalase TCCTGAGAGAGTCGTGCACG
Catalase TCCTGAGAGAGTCGTGCACG
SOD-1 TGATCATGGATTCCACGTC
Nrf2 CAGCACAACACATACCATCAG
GAPDH GTGAAGGTCGGAGTGAACGReagent for 30 min at 37 C following manufacturer’s instructions.
Fluorescence intensity was analyzed by a Wallac ARVO MX 1420
multilabel counter (Perkin Elmer Japan, Kanagawa, Japan).
2.3. siRNA transfection
For the gene knock-down experiments, chondrocytes at passage
2 were seeded onto 48-well multiplates and cultured in the
serum-free medium for 24 h. Then a mixture of three speciﬁc
siRNAs (Table 1) was transfected into chondrocytes using
Lipofectamine RNAiMAX Reagent (Life Technologies) according to
the manufacturer’s protocol. Twelve hours later, the complexes
were removed from the 48-well plates, cells were washed with
PBS, and 400 ll fresh serum-free medium containing the reagents
of interest was added to the plates. The controls treated with
scrambled siRNA at the same concentration were analyzed in
parallel.
2.4. Western blot analysis
After each treatment, cells were lysed with SDS buffer (4% SDS,
125 mM tris–HCl, 10% 2-mercaptoethanol, 0.01% bromophenol
blue in 20% glycerol) then the total cell lysates were separated
by SDS–PAGE and transferred to polyvinylidene diﬂuoride (PVDF)
membranes. (Hybond-P; Amersham Pharmacia Biotech,
Buckinghamshire, UK). The blotted membranes were blocked at
room temperature for 1 h with Block Ace (Dainippon
Pharmaceutical, Osaka, Japan) and treated with following primary
antibodies overnight at 4 C; Phospho-p38 MAPK (Thr180/Tyr182)
(D3F9) XP rabbit monoclonal antibody (Cell Signaling Technology,
Danvers, MA, USA), p38 MAPK rabbit polyclonal antibody (Cell
Signaling Technology), Phospho-p44/42 MAPK (ERK1/2)
(Thr202/204) rabbit polyclonal antibody (Cell Signaling
Technology), p44/42 MAPK (ERK1/2) (137F5) rabbit monoclonal
antibody (Cell Signaling Technology), Phospho-Akt (Ser473)
(D9E) XP rabbit monoclonal antibody (Cell Signaling Technology),
Akt rabbit polyclonal antibody (Cell Signaling Technology), Keap1
(D6B12) rabbit monoclonal antibody (Cell Signaling Technology),
Nrf2 (C-20) rabbit polyclonal antibody (Santa Cruz Biotechnology,
Santa Cruz, CA, USA) and GAPDH mouse polyclonal antibody
(Abnova, Taipei, Taiwan) followed by a peroxidase-conjugated
anti-rabbit or mouse IgG antibody (Santa Cruz Biotechnology).
Detection was realized by enhanced chemiluminescence with an
ECL prime western blotting detection reagent (Amersham
Pharmacia Biotech, Buckinghamshire, UK) and horseradish peroxi-
dase (HRP)-conjugated secondary antibodies (all were purchased
from Santa Cruz Biotechnology) corresponding to each primary
antibody. The lumino-labeled membranes were analyzed by the
CCD-based chemiluminescent analyzer LAS 4000 (GE Healthcare,
Tokyo, Japan).Reverse
CTTGTAATCTGGGTGGTCCTTCTT
CTCGTCCACCGTCCTTCCC
TGGTAGGTCCAGCAAACAG
C TTGCGTTCGATCTCCTCCTC
ACAGTCTCGGCAGGATACTG
ACGTACTTCAGGCAATTCAGG
CGTCCTCTTTCCAATATGCTC
CGTCCTCTTTCCAATATGCTC
GGACAGAGGATTAAAGTGAGG
TGCATGCAGTCATCGAAGTAC
TAAAAGCAGCCCTGGTGAC
Fig. 1. HA decreased ROS accumulation in H2O2 treated chondrocytes. (A) CellROX-based assay for observing ROS levels of the chondrocytes. HA addition decreases ROS levels
detected as the CellROX ﬂuorescence intensity. Bars showmeans ± SD of the results obtained by three independent experiments. An asterisk indicates signiﬁcant difference at
P < 0.05. (B) Western blot analysis for phosphorylation status of the redox-induced MAPK p38. (C) qRT-PCR analysis for the matrix related genes Sox9 and Col2A1 and
catabolic gene Adamts-5. Bars show means ± SD of the results obtained by three independent experiments. Means with different letters are signiﬁcantly different at P < 0.05.
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Total RNA was extracted with the TRIzol reagent (Invitrogen)
and reverse transcribed with the High Capacity cDNA reverse tran-
scription kit (Applied Biosystems, Foster City, CA, USA). The
qRT-PCR with total cDNA was performed using Perfect real-time
SYBR green II (Takara Bio, Inc., Shiga, Japan) with appropriate pri-
mer sets (Table 2) in the Thermal Cycler Dice Real Time System
(Takara Bio, Inc.) at 95 C for 20 s followed by 40 cycles of 95 C
for 5 s, 60 C for 30 s. To quantify the relative expression of each
gene, the Ct (threshold cycle) values were normalized to an
endogenous reference (DCt = Cttarget  CtGapdh) and compared with
a calibrator (control), using the DDCt method (DDCt =
DCtsample  DCtcalibrator).
2.6. Statistical analysis
Signiﬁcant difference was detected by Tukey–Kramer HSD test
or Student’s t-test. A P-value of less than 0.05 was considered
signiﬁcant.3. Results
As the ﬁrst step of the study, we determined the antioxidant
effect of HA in cultured bovine articular chondrocytes. To observe
accumulation of ROS in the cells in response to hydrogen peroxide
(H2O2) stimulation, we used CellROX Green Reagent that is a ﬂuo-
rogenic probe for measuring oxidative stress in live cells. By using
CellROX, we could observe that H2O2 addition induced ROS accu-
mulation in the chondrocytes, and this was inhibited by HA sup-
plementation (Fig. 1A). ROS treatment decreased matrix anabolic
factors Sox9 and Col2A1, while matrix degradation factor
Adamts-5 was elevated. The addition of HA completely blocked
the inhibitory effect of ROS on Sox9 and Col2A1 while signiﬁcantly
reducing Adamts-5. ROS also increased phosphorylation of p38
MAP kinase, which is an important indicator and mediator of
oxidative stress, and this was reduced by HA (Fig. 1B and C).
These results indicate that H2O2 induced ROS elevation is detri-
mental to matrix maintenance, and HA supplementation can func-
tion as an antioxidative factor to assuage the catabolic changes at
gene expressions level in the cultured chondrocytes.
Fig. 2. HA enhanced gene expression levels of the antioxidant and phase II detoxifying enzymes via increasing the Nrf2 expression level. (A) Quantitative RT-PCR analysis of
gene expression levels of HO-1, NQO-1, GPX-1, Catalase and SOD1 in the HA treated/non-treated chondrocytes at 24 h of treatments. Bars show means ± SD of the results
obtained by three independent experiments. Asterisks indicate signiﬁcant differences at P < 0.05 compared with the untreated controls. (B) qRT-PCR and western blot analysis
with the chondrocytes treated HA for 24 h. Bars show means ± SD of the results obtained by three independent experiments. An asterisk indicates signiﬁcant difference at
P < 0.05 with the untreated control. (C) Western blot analysis of the cytoplasmic and nuclear Nrf2 expression levels. Chondrocytes were treated with HA for 24 h.
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exhibited through elevation of ROS neutralizing enzymes. After
24 h of HA treatment, we could observe increased HO-1, NQO-1,
GPX-1 and catalase gene expression (Fig. 2A). Since these phase
II detoxifying enzymes are controlled by a master transcription fac-
tor Nrf2, we analyzed Nrf2 expression levels both at gene and pro-
tein level. We could detect increased Nrf2 expression both at
transcription and protein levels in response to HA (Fig. 2B).
Increased Nrf2 protein was detected in both cytoplasmic and
nuclear compartments (Fig. 2C). Expression level of Keap1, which
is an important post-transcriptional negative regulator of Nrf2,
did not change.
Next, we examined if HA-induced increase in Nrf2 is actually
linked to anti-oxidative stress potential of the cultured chondro-
cytes using speciﬁc siRNA oligonucleotides (siNrf2) which dimin-
ished Nrf2 mRNA to 20% of control cells that were treated with
random RNA oligonucleotides (scramble, SCR). In the
Nrf2-knocked-down chondrocytes, basal ROS level was elevated,
and phosphorylation of p38 was induced (Fig. 3A). Furthermore,
in the Nrf2-knocked-down chondrocytes, reduced Sox9 and
Col2A1 and increased Adamts-5 mRNA levels were detected
(Fig. 3B).
To elucidate mechanism of the HA-induced Nrf2 accumulation,
we analyzed phosphorylation status of Akt, which is known as an
upstream regulator of the Nrf2 stabilization. When we quantiﬁed
changes of phosphorylated Akt and Nrf2 after HA addition to the
chondrocytes, both proteins showed time-dependent increases
(Fig. 4A–C). To conﬁrm that the HA-induced Nrf2 accumulation isAkt-phosphorylation dependent, we added the Akt speciﬁc inhibi-
tor LY294002 and performed western blot analysis. LY294002
treatment inhibited Akt phosphorylation without changing of the
amount of total Akt protein, and it also diminished Nrf2 gene
expression and protein accumulation (Fig. 5A). In the Akt inhibited
condition, gene expressions of Sox9 and Col2A1 decreased, but the
expression level of Adamts-5 increased (Fig. 5B).
As the last part of the study, we determined whether the HA
dependent regulation of Nrf2 expression occurred through interac-
tion of HA with its speciﬁc receptors CD44 and RHAMM on the
chondrocytes by inhibiting their expression. Introduction of the
speciﬁc oligonucleotide towards CD44 and RHAMM (siCD44 and
siRHAMM) decreased mRNA levels of the each gene. Importantly,
HA-induced Akt phosphorylation, Nrf2 gene expression and Nrf2
protein accumulation were blocked in the CD44- and
RHAMM-knocked-down chondrocytes (Fig. 6A and B).
Furthermore, intra-cellular ROS was also increased in the CD44
and RHAMM-knocked-down cells (Fig. 6C). From these results, it
could be concluded that the HA-induced Nrf2 accumulation in
chondrocytes occurred through interaction of HA with its speciﬁc
receptors CD44 and RHAMM.4. Discussion
This study examined the hypothesis that the protective effects
of HA in chondrocytes may be related to enhancement of the
Nrf2-mediated antioxidation potential. Our results demonstrate
Fig. 3. Nrf2 is a critical factor to scavenge ROS in chondrocytes. (A) Quantitative RT-PCR for gene expression levels of Nrf2 after siNrf2 treatment. Bars showmeans ± SD of the
results obtained by three independent experiments. Asterisks indicate signiﬁcant differences at P < 0.05 compared with the untreated controls (left). Western blot analysis for
the siNrf2 treated chondrocytes to detect p38 phosphorylation as an intracellular ROS messenger (center, upper panel). Densitometric quantiﬁcation of western blot for Nrf2
in the siNrf2 treated chondrocytes (center, lower panel). CellROX-based assay for observing ROS levels of the siNrf2-treated chondrocytes (right). Cont means non-treated
control and SCR means scrambled siRNA treated cells. (B) Quantitative RT-PCR for gene expression levels of Sox9, Col2A1 and Adamts-5. SCR means scrambled siRNA treated
cells. Bars show means ± SD of the results obtained by three independent experiments. Means with different letters are signiﬁcantly different at P < 0.05.
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HA supplementation results in the chondrocyte speciﬁc matrix-
related gene expression. In a previous study, we demonstrated
that HA can enter into the central layer of the cartilage tissue,
and can support reduction of the mechanical stress-induced ROS
[19]. The results of the present study are consistent with the
previous results, and suggest that the antioxidation properties
of HA are an important biological effect in vitro (cultured cells)
[39] and ex vivo (tissues) [19]. However, it is unknown whether
the antioxidant effect of HA is derived from physical properties
of the HA itself or results from a biosynthetic response of the
chondrocytes to the HA.
Therefore, we addressed mechanisms mediating the effect of
HA in cultured articular chondrocytes. By adding HA, we found that
HA induced accumulation of the critical transcriptional factor Nrf2,
and led to corresponding changes in target gene expressions. These
results suggested that the effect of HA on the chondrocytes is not
due to the chemical properties of the HA, but occurred through bio-
logical mechanisms and activation of intracellular signal transduc-
tion. Until now, the fact that HA contributes to upregulation of
gene expression of the antioxidative stress-related enzymes has
not been reported, but there is some prior evidence that HA mod-
ulates expression of some genes via its speciﬁc receptors CD44
[40,41] or/and RHAMM [42–44].Furthermore, we tried to elucidate the mechanism how HA
induces Nrf2 accumulation by focusing on Akt activity-dependent
regulation of the Nrf2 stabilization system. Nrf2 is mainly regu-
lated at the post-transcriptional level. Under normal conditions,
Nrf2 is constantly degraded via the ubiquitin–proteasome pathway
in a Kelch-like ECH-associated protein (KEAP1)-dependent manner
[27,28,31]. In the presence of ROS, the Keap1–Nrf2 connection and
subsequent Nrf2 degradation process ceases, Nrf2 is stabilized, and
can function as a transcriptional regulator through binding to
antioxidant response element (ARE) on the promoter region of
the target genes [25,27]. To date, interactions between the
Keap1–Nrf2 system and other signaling pathways have been
examined in some cell types. For example, some previous studies
with cancer cell-lines reported that PI3K/Akt activation is impor-
tant for the Nrf2 stabilization and activation [45–47]. Wang et al.
demonstrated that constitutively active Akt enhanced Nrf2 activity
using a retinal pigment epithelia (RPE) cell line [48]. In our study,
induction of the Akt phosphorylation by HA addition was observed
consistent with ﬁndings in other cell types. Furthermore,
HA-induced Nrf2 accumulation was blocked by treatment with
the Akt inhibitor LY294002 or siRNAs towards HA receptors
CD44 and RHAMM. These results suggest that HA affects Nrf2 reg-
ulation through interaction with CD44/RHAMM and uses Akt as
important intracellular messenger.
Fig. 4. HA-induced Nrf2 accumulation in chondrocytes was mediated by enhancement of Akt phosphorylation. (A) Western blot analysis for the HA treated chondrocytes to
observe Akt phosphorylation and Nrf2 accumulation at each time point after HA addition. (B) Densitometric quantiﬁcation of western blot for Nrf2. Values were normalized
by GAPDH. (C) Densitometric quantiﬁcation of western blot for phosphorylated Akt. Values were normalized by total Akt.
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ofmechanisms and consequences. First is a reactive accumulationof
Nrf2 towards the ROS generation as described above. Second is a
stockpiling against potential risk of ROS [27,46,49,50]. The actual
meaning of the latter has not been well understood, but it appears
that the steady state activation of Nrf2 provides cytoprotection
against oxidant stress. Interestingly, Wruck et al., reported that
Nrf2 KOmice hadmore severe cartilage injuries andmore oxidative
damage during antibody-induced arthritis (AIA) [51]. It is possible
that thesemice are susceptible to accumulate oxidative stress dam-
age because of their deﬁciency in neutralizing ROS.
In developing cartilage of mice, Nrf2 expression is observed in
proliferating and pre-hypertrophic chondrocytes in tibia at E15.5,
and the expression is maintained in all chondrocyte layers and
osteoblasts in cancellous bone after birth [52]. Since normal carti-
lage is an avascular tissue, chondrocytes basically exist in very
hypoxic environment. Once inﬂammation or vascular invasion
occurs, chondrocytes are exposed to enhanced oxidative stresses.
Furthermore, compressive mechanical stress induced by excessive
exercise or trauma can also be an important source of oxidative
stress. Therefore, the previous observation that Nrf2 proteins
reside in all layers of cartilage is consistent with the necessities
of chondrocyte to protect against the potential risks of oxidativestresses. We also examined here the importance of the Nrf2
expression by comparing the Nrf2 knocked-down chondrocytes
with normal chondrocytes. In our experiments, decreased expres-
sion of cartilage matrix gene Col2A1, and of the cartilage develop-
ment related gene Sox9 were observed. In addition, there was
reduced expression of genes encoding anti-oxidative stress mole-
cules, and increased gene expression of Adamts-5, an important
catabolic molecule for cartilage matrix. Since Nrf2 expression is
observed also in normal cartilage development and there is evi-
dence suggesting that Nrf2 contributes to control of some meta-
bolic genes and transcription factors and cell cycle regulators, it
is possible that Nrf2 directly regulates cartilage matrix-related
gene expression.
Although further evidences including epidemiological studies
are essential to link HA levels, Nrf2 stockpile and OA pathogenesis,
our results provide an advance in elucidating an important protec-
tive mechanism in chondrocyte homeostasis.Author contributions
YO and TT wrote the manuscript. TT and KF designed the study
and experiments. YO and TT performed the experiments.
Fig. 5. (A) qRT-PCR and western blot analysis for the chondrocytes treated with HA and Akt speciﬁc inhibitor LY294002 (Akti) for 24 h to observe Akt phosphorylation and
Nrf2. Control (without LY294002) groups were treated with DMSO. Bars show means ± SD of the results obtained by three independent experiments. An asterisk indicates
signiﬁcant difference at P < 0.05 with the untreated control. (B) Quantitative RT-PCR observation for gene expression levels of Keap1, Sox9, Col2A1 and ADAMTS5 in the HA/
LY294002 treated chondrocytes. Control (without LY294002) groups were treated with DMSO. Bars show means ± SD of the results obtained by three independent
experiments. Means with different letters are signiﬁcantly different at P < 0.05.
Fig. 6. HA induced Akt phosphorylation and Nrf2 expression via HA receptors CD44 and RHAMM. (A) Quantitative RT-PCR for Nrf2 in the siCD44/siRHAMM treated
chondrocytes at 24 h after HA treatment. Bars show means ± S.D of the results obtained by three independent experiments. Experimental group of siCD44 () and siRHAMM
() was treated with scrambled sequence RNA as control. An asterisk indicates signiﬁcant difference at P < 0.05 with the untreated control. (B) Western blot analysis for Akt
phosphorylation and Nrf2 expression levels in the HA receptors CD44 and RHAMM-knocked-down chondrocytes after HA treatment. (C) Quantiﬁcation of intracellular ROS by
CellROX in the CD44 and RHAMM-knocked-down chondrocytes.
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